GN Store Nord (GN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Q1 2025 group organic revenue declined by 3% year-over-year excluding wind-down, with reported organic growth at -8% and total revenue at DKK 3,986 million, impacted by market uncertainty and U.S. tariffs.
Strong product launches, notably ReSound Vivia in hearing and new gaming products, drove market share gains and customer engagement, partially offsetting declines.
Enterprise faced a weak European market and tough comps but maintained market leadership and robust margins through pricing discipline.
Proactive cost mitigation, supply chain diversification, and price increases were implemented to support margins and cash flow.
EBITA dropped 44% to DKK 300 million (margin 7.5%), reflecting negative operating leverage and launch costs.
Financial highlights
Group organic revenue growth was -3% year-over-year excluding wind-down; hearing declined -1%, enterprise -9%, and gaming grew 11%.
Gross margin improved to 54.9% (up 2 percentage points year-over-year), aided by group synergies but offset by business mix and tariffs.
EBITA was DKK 300 million (margin 7.5%, down from 12.5%); EBITDA margin at 8%.
Free cash flow excl. M&A was DKK -395 million, affected by seasonality, higher interest, and tax payments.
Adjusted leverage ended at 4.1x; net interest-bearing debt at DKK 10,145 million.
Outlook and guidance
2025 group organic revenue growth guidance is -3% to +3% (excluding wind-down), with EBITA/EBITDA margin guidance at 11%-13%.
Free cash flow (excluding M&A) expected to be around DKK -800 million for the year.
Hearing division expected to deliver 5%-9% organic revenue growth, enterprise -8% to 0%, and gaming -6% to 2%.
Margin improvement expected in subsequent quarters, with Q1 being the lowest for the year.
Guidance assumes current tariff rates and continued market uncertainty, especially in Enterprise and Gaming.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement8 Jul 2026 - Hearing sale announced; EBITA margin drops, cost savings and 2026 growth targeted.GN
Q1 20267 May 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025